Singapore, Nov. 10 -- HarbourBioMed, a global biopharmaceutical company committed to the discoveryand development of novel antibody therapeutics in immunology and oncology, andEvinova, a global health-tech company accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, have announced a strategiccollaboration in artificial intelligence (AI).

Published by HT Digital Content Services with permission from BioSpectrum Asia....